"Frontiers in Clinical Drug Research - Anti-Cancer Agents is an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.
The third volume of the eBook series begins with a detailed review of the molecular biology of inhibitors that target EGF-family receptors. This review is divided into two parts that covers extracellular and intracellular molecules. Other reviews cover targeted therapies for cancers such as melanoma, follicular lymphoma and topics such as cancer immunotherapy, apoptosis targeting and the Warburg Effect."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

End User License Agreement (for non-institutional, personal use)

2. LINKING THE EGFR WITH CANCER THERAPUTICS

4. BIOMARKERS PREDICTING SENSITIVITY AND RESISTANCE TO ANTI-EGFR THERAPIES - LIGANDS OF THE EGFR AS PREDICTORS OF RESPONSE TO ANTI-EGFR THERAPY

5. BIOMARKERS PREDICTING SENSITIVITY AND RESISTANCE TO ANTI-EGFR THERAPIES - ALTERATIONS IN ERBB RECEPTORS FAMILY MEMBERS

6. Alterations in Non-ErbB Receptor Family Members

Tumor Resistance Mechanisms to Inhibitors Targeting the Epidermal Growth Factor Receptor– Part I: Extracellular Molecules

2. INTRACELLULAR TRAFFICKING OF THE egfr AND RESISTANCE TO ANTI-eGFR Therapy

3. The ras/ref/mek/erk Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

4. The PI3-K Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

5. ANALYSIS OF SEVERAL BIOMARKERS IN COMBINATION AND RESISTANCE TO ANTI-eGFR Therapy

6. The JAK/STAT Signaling Pathway AND RESISTANCE TO ANTI-eGFR Therapy

Tumor Resistance Mechanisms to Inhibitors Targeting the Epidermal Growth Factor Receptor – Part II: Intracellular Molecules

Chemotherapeutic, Immunologic, and Molecularly Targeted Therapy for the Treatment of Advanced Melanoma

1. THERAPEUTICAL APPROACHES TO CANCER: FROM Chemotherapy to Targeted Therapies

3. THE WARBURG EFFECT: CURRENT PERSPECTIVE

4. CURRENT AND PAST EFFORTS AT TARGETING THE WARBURG EFFECT FOR CANCER THERAPY

Targeting the Warburg Effect for Cancer Therapy: A Long and Winding Road

3. Previous Considerations before Therapy

6. Novel and Emerging Pharmacological Agents

7. Innovative Immunotherapy Strategies for Treatment of FL

Immunotherapy Strategies in Follicular Lymphoma: Antibodies, Vaccines and Cells

Cancer Epigenetics AND Role in Carcinogenesis

Modulation of Metabolism by Epigenetic Dys-regulation

Epigenetic Regulation by the Availability of Co-substrates

Epigenetic Dysregulation Induced by Oncometabolites

Epigenetics and Cancer Cell Metabolism: Cross-talk and Therapeutic Opportunities

Apoptosis Targeting Therapeutics in Clinical Trials

Bentham Science Publishers

"Frontiers in Clinical Drug Research – Anti infectives is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the book series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
 
 
 
The eighth volume of this series presents comprehensive reviews of interest to readers interested in the treatment of inflammatory diseases, new antiviral agents and strategies, specific antiprotozoal drugs that work against leishmania and helminths,  and a study on potential agents against American foulbrood in honey bees. The 7 reviews included in this volume are:
 
- Monoclonal antibodies as therapeutic agents for inflammatory diseases
 
- Pharmacotherapy of emerging antiviral agents
 
- Antiviral activity of vitamin D and COVID-19: current understanding
 
- Anti-infectives to combat leishmaniasis
 
- Anthelmintic drug discovery: current situation and future perspectives
 
- Therapeutic targets for emerging Zika virus infection and vaccines in clinical trials
 
- Agro-industrial waste: new source of raw material for the control of American foulbrood in honey bees"


Frontiers in Clinical Drug Research - Anti Infectives: Volume 8

Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The sixth volume of this series features 6 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist. - The failing heart in diabetes with special emphasis on prevention- Flavonoids as prominent anti-diabetic agents- Chemosensor in glucose monitoring, advances and challenges - Synergistic drugs and polyherbal formulations for obesity: current status and future prospectives- Urge for herbal anti-diabetic medicines towards clinical and therapeutic implications- Curcuma longa as a dietary supplement and medication for diabetes mellitus: evidence from experimental studies


Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 6

"Frontiers in Drug Design and Discovery is an eBook series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists have contributed chapters focused on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. This eBook series should prove to be of interest to all pharmaceutical scientists who are involved in research in drug design and discovery and who wish to keep abreast of rapid and important developments in the field.
 
The seventh volume of this series brings together seven reviews covering chemotherapeutic agents, antimicrobials and phytochemicals.
 
Some topics included in this volume are:
 
    Metabolic pathways and chemotherapy drugs
    Cardiotoxicity of cancer chemotherapy
    Nanotherapeutics for infectious diseases
    Natural sources of angiogenesis inhibitors
 
…and much more."


Frontiers in Drug Design & Discovery: Volume 7

"Frontiers in Clinical Drug Research – HIV is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of acquired immune deficiency syndrome (AIDS) and other disorders associated with human immunodeficiency virus (HIV) infection. The scope of the book series covers a range of topics including the medicinal chemistry and pharmacology of natural and synthetic drugs employed in the treatment of AIDS (including HAART) and resulting complications, and the virology and immunological study of HIV and related viruses. Frontiers in Clinical Drug Research – HIV is a valuable resource for pharmaceutical scientists, clinicians and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in HIV/AIDS research.
The fourth volume of this series features 5 chapters that cover these topics: 
- Design and Synthesis of HIV-1 Protease Inhibitors
- Potential Magnetic Nanotherapeutics for Management of neuroAIDS
- Syntheses of FDA Approved Integrase Inhibitor HIV Drugs and Improved Manufacturing using Flow Processing
- The Development and Clinical Progress on Chemokine Receptor-Based HIV Entry Inhibitors
- Sexually Transmitted Co-infections in Persons Living with HIV"


Frontiers in Clinical Drug Research - HIV: Volume 4

"Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.
 
The fifth volume of the book features reviews on biochemical inhibitors (second-generation protein kinase Inhibitors, histone deacetylase inhibitors, immune checkpoint inhibitors, EGFR Tyrosine Kinase inhibitors, non-coding RNAs), apoptosis, and physical exercise therapy for cancer patients undergoing chemotherapy. The treatment strategies in this volume cover cancers such as acute myeloid leukemia, gastrointestinal cancer, breast cancer and lung cancer."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5

"Frontiers in Clinical Drug Research – Central Nervous System presents the latest researches and clinical studies on the central nervous system (CNS). It covers a range of topics such as the development and pathophysiology of the brain and spinal cord, physiological sites of drug action in the CNS and clinical findings on drugs used to treat CNS defects due to injury or impaired development. In addition to clinical research on humans, the book also highlights other avenues of CNS medicine and research such as pain medicine, stem cell research, pharmacology, toxicology and translational models in animals.   
The second volume of the series features chapters on the following topics: 
- Nucleic acids as drugs for neurodegenerative diseases
- Cellular Cysteine Network (CYSTEINET):
- Non-motor Symptoms in Parkinson’s Disease and drug therapies
- Multi-modal pharmacological treatments for major depressive disorder"


Frontiers in Clinical Drug Research - Central Nervous System: Volume 2

"Frontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
 
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimer’s Disease research.
 
The fifth volume of this series features chapters covering critical discussions on AD management and new therapies. The topics reviewed in this volume include:
- Current concepts in management of AD
- The amyloid cascade hypothesis and stem cell-based AD therapy 
- Phytochemicals targeting AD
- Dementia screening in primary clinical care settings
- Updates in dementia / AD clinical research and drug development"


Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 5

"This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
 
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
 
The eighth volume of this series features 8 chapters that cover methods for antimicrobial drug discovery (with 2 chapters that focus on genomics) as well as updates on drug development against Helicobacter pylori and emerging coronaviruses, among other interesting topics:
 
 
 
- Eradication of Helicobacter pylori Infection with Non-Bismuth Quadruple Concomitant Therapy
 
- Drug Discovery Strategies Against Emerging Coronaviruses: A Global Threat
 
- Opportunities Offered By Fragment-Based Drug Design in Antibiotic Development
 
- Phage therapy as a Tool for Control of Foodborne Diseases: Advantages and Limitations
 
- Subtractive Genomics Approaches: Towards Anti-Bacterial Drug Discovery
 
- Recent Advances in the Discovery of Antimicrobials through Metagenomics
 
- Phyto-Nano-Antimicrobials: Synthesis, Characterization, Discovery, and Advances
 
- Aptamers as Anti-infective Agents"


Frontiers in Anti-Infective Drug Discovery: Volume 8

Dr. M. lqbal Choudhary 

"Frontiers in Medicinal Chemistry is an Ebook series devoted to the review of areas of important topical interest to medicinal chemists and others in allied disciplines. Frontiers in Medicinal Chemistry covers all the areas of medicinal chemistry, including developments in rational drug design, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, chemoinformatics, and structure-activity relationships.  This Ebook series is essential for any medicinal chemist who wishes to be kept informed and up-to-date with the latest and the most important advances.
This volume features reviews on the following topics:
ADME optimization and toxicity assessment in drug discovery
Targeting oxidative stress mechanisms in vascular disease therapy
Diabetes therapy that targets endothelial function
… and more."


Frontiers in Medicinal Chemistry: Volume 8

"Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come. Challenges in the 21st century to combat diseases such as cancer, Alzheimer’s disease and retinal disorders, among others, may well be addressed employing stem cell therapies and tissue regeneration techniques. Frontiers in Stem Cell and Regenerative Medicine Research is essential reading for researchers seeking updates in stem cell therapeutics and regenerative medicine.
 
This volume includes current literature on a variety of topics:
 
-the utility of exogenous and endogenous neural stem cells in spinal cord injury
 
-somatic cells for human induced pluripotent stem cells (iPSCs)
 
-reactive oxygen species (ROS) mediated cellular signaling for stem cell differentiation
 
-the therapeutic potential of microRNAs in cardiac diseases
 
-stem cell therapy for the treatment of malaria"


Sepetiniz

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 3

$ 99.00

description_of_book

Ek Bilgi

Yazarlar Hakkında

Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti Infectives: Volume 8

Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 6

Frontiers in Drug Design & Discovery: Volume 7

Frontiers in Clinical Drug Research - HIV: Volume 4

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 5

Frontiers in Clinical Drug Research - Central Nervous System: Volume 2

Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 5

Frontiers in Anti-Infective Drug Discovery: Volume 8

Frontiers in Medicinal Chemistry: Volume 8

Frontiers in Stem Cell and Regenerative Medicine Research: Volume 9

Atta-ur-Rahman